Why clinical trials on nutritional supplements are hard to design
Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising everything…
Klothea initiates longevity-focused human trial of klotho therapy
Recruitment for Phase 1 trial of mRNA therapy begins in ‘special economic zone’ on the Caribbean island of…
Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)
Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…
Fact Check Team: GLP-1 users getting rare pirate disease
WASHINGTON (TNND) — Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from…
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals – Endpoints News
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals Endpoints NewsCompass Pathways to Announce New…
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Disc Medicine Inc FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and…
FDA clears first human trial of epigenetic reprogramming therapy
A milestone moment for longevity as Life Biosciences gets green light to progress cellular rejuvenation trial in eye…
All the economic wins Keir Starmer wants to bag in China – POLITICO
For now, then, the aim is to secure progress in areas that are seen as less sensitive. Starmer’s…
Rheumatoid arthritis has no cure – but researchers are homing in on preventing it
But multiple studies have now confirmed that rheumatoid arthritis has a preclinical stage of development. This is a time about three…
Tailored Treatment Approach Shows Promise for Reducing Suicide and Self-Harm Risk in Teens and Young Adults
Newswise — A new study by UCLA and Kaiser Permanente Northwest’s Center for Health Research demonstrates a health…
Juvena lands $33.5m to advance more regenerative biologics to the clinic
Co-founder Hanadie Yousef to step down as CEO as company gears up for more clinical trials of drugs…
$3.3M Trial of Ai-Designed Bacteriophage Therapy for HAP/VAP
Locus Biosciences will conduct a clinical trial for its Ai-designed bacteriophage therapeutic for HAP/VAP caused by antibiotic-resistant P. aeruginosa.…